Desq Long
Sign in

Company

TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA · CIK 0000818686

SEC FORM 4
$14,356,801.80

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Sale of 367,600 shares at $39.0555 per share.

Reporting Person MIGNONE ROBERTO · Transaction Code S

Traded Sep 18, 2026 · Disclosed Sep 22, 2026

Source: SEC Form 4 · 0001193125-26-397959 · filed 2026-09-22 · View filing →

SEC FORM 4
$156,254.10

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Acquisition (code M) of 4,503 shares at $34.7 per share.

Reporting Person Savage Brian · Officer Title Interim Chief Legal Officer · Transaction Code M

Traded Sep 18, 2026 · Disclosed Sep 22, 2026

Source: SEC Form 4 · 0001193125-26-398105 · filed 2026-09-22 · View filing →

SEC FORM 4
$174,221.07

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Sale of 4,503 shares at $38.69 per share.

Reporting Person Savage Brian · Officer Title Interim Chief Legal Officer · Transaction Code S

Traded Sep 18, 2026 · Disclosed Sep 22, 2026

Source: SEC Form 4 · 0001193125-26-398105 · filed 2026-09-22 · View filing →

SEC FORM 4
$98,841.13

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Sale of 2,525 shares at $39.145 per share.

Reporting Person Savage Brian · Officer Title Interim Chief Legal Officer · Transaction Code S

Traded Sep 18, 2026 · Disclosed Sep 22, 2026

Source: SEC Form 4 · 0001193125-26-398105 · filed 2026-09-22 · View filing →

SEC FORM 4
$12,152.99

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Sale of 314 shares at $38.7038 per share.

Reporting Person Savage Brian · Officer Title Interim Chief Legal Officer · Transaction Code S

Traded Sep 18, 2026 · Disclosed Sep 22, 2026

Source: SEC Form 4 · 0001193125-26-398105 · filed 2026-09-22 · View filing →

SEC FORM 4
$15,458.75

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Sale of 415 shares at $37.25 per share.

Reporting Person Satchi-Fainaro Ronit · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001193125-26-365107 · filed 2026-08-25 · View filing →

SEC FORM 4
$261,224.37

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Sale of 6,945 shares at $37.6133 per share.

Reporting Person Weiss Amir · Officer Title Chief Accounting Officer · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001193125-26-365116 · filed 2026-08-25 · View filing →

SEC FORM 4
$49,025.00

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Acquisition (code M) of 2,500 shares at $19.61 per share.

Reporting Person Weiss Amir · Officer Title Chief Accounting Officer · Transaction Code M

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001193125-26-365116 · filed 2026-08-25 · View filing →

SEC FORM 4
$94,076.75

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Sale of 2,500 shares at $37.6307 per share.

Reporting Person Weiss Amir · Officer Title Chief Accounting Officer · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001193125-26-365116 · filed 2026-08-25 · View filing →

SEC FORM 4
$680,291.28

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Sale of 18,600 shares at $36.5748 per share.

Reporting Person Lippman Evan · Officer Title EVP, Business Development · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001193125-26-356853 · filed 2026-08-19 · View filing →